CPD Events

Parkinson's Review Meeting 2017

06 Oct 2017

About the event

This event provides an overview of the latest research developments in Parkinson's: Optimising methods of achieving true continuous drug delivery; Latest developments in treatment guidelines including NICE; Latest study date for Apomorphine including TOLEDO & PK-APO.

CPD Provider

Britannia Pharmaceuticals

Send an enquiry

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Britannia Pharmaceuticals

Britannia Pharmaceuticals

Britannia Pharmaceuticals, part of the STADA Arzneimittel AG group of companies, is a UK based pharmaceutical company. We specialise in innovative products for chronic and serious medical conditions, and in particular, the treatment of Parkinson’s disease. We are highly committed to improving the quality of life for People with Parkinson's disease.

Want to learn more?